title: Onset of severe perianal disease in Crohn's disease under treatment with infliximab: successful treatment with adalimumab and setons drainage.
authors.forename: Antonio
authors.initials: A
authors.lastname: Tursi
authors.forename: Alfredo
authors.initials: A
authors.lastname: Papa
authors.forename: Michele
authors.initials: M
authors.lastname: Maiorano
mesh_terms: D000068879:Adalimumab; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001004:Anus Diseases / Q000188:drug therapy* / Q000209:etiology*; D003424:Crohn Disease / Q000150:complications*; D004322:Drainage; D005260:Female; D006801:Humans; D000069285:Infliximab; D010502:Perineum / Q000473:pathology*; D012003:Rectal Fistula / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab